So Dr T now you really are an insider and obviously know everything that’s going on, what’s your take on the COH deal. Some have said this was the jewel in DCB,s tenure, but the lack of noise makes me think perhaps this jewel is more of a lead weight. I know you probably can’t say too much, but would be interested in any comments you have without divulging ps information.
Ann: Dr Daniel Tillett appointed CEO of Race Oncology, page-70
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
